https://www.selleckchem.com/pr....oducts/sacituzumab-g
All patients remain disease-free at median follow-up of 19months (range, 12-30months). Our experience continues to evolve, and suggests that robotic surgery is safe, feasible and oncologically effective for resection of adrenal masses in well-selected pediatric patients. Our experience continues to evolve, and suggests that robotic surgery is safe, feasible and oncologically effective for resection of adrenal masses in well-selected pediatric patients. The pandemic of COVID-19 has occurred close on the heels of a global re
Like
Comment
Share
